The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
ECM remodeling in hypertensive heart disease
Open accessAbstract
Hypertensive heart disease (HHD) occurs in patients that clinically have both diastolic and systolic heart failure and will soon become the most common cause of heart failure. Two key aspects of heart failure secondary to HHD are the relatively highly prevalent LV hypertrophy and cardiac fibrosis, caused by changes in the local and systemic neurohormonal environment. The fibrotic state is marked by changes in the balance between MMPs and their inhibitors, which alter the composition of the ECM. Importantly, the fibrotic ECM impairs cardiomyocyte function. Recent research suggests that therapies targeting the expression, synthesis, or activation of the enzymes responsible for ECM homeostasis might represent novel opportunities to modify the natural progression of HHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis, Z. S., & Khatri, J. J. (2002) · PubMed · Cited by 1,787
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Galis, Z. S., & Khatri, J. J. (2002) · Circulation Research · doi:10.1161/res.90.3.251 · Cited by 1,548
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,184
Cardiac interstitium in health and disease: The fibrillar collagen network
Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,056
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1202.105290 · Cited by 887
The Pathogenesis of Acute Pulmonary Edema Associated with Hypertension
Gandhi, S. K., Powers, J. C., Nomeir, A.-M., Fowle, K., Kitzman, D. W., Rankin, K. M., & Little, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440103 · Cited by 733
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Miner, J. H., Patton, B. L., Lentz, S. I., Gilbert, D. J., Snider, W. D., Jenkins, N. A., Copeland, N. G., & Sanes, J. R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.3.685 · Cited by 660
Bagrodia, S., Dérijard, B., Davis, R. J., & Cerione, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.27995 · Cited by 635
Chemotactic activity of elastin-derived peptides.
Senior, R. M., Griffin, G. L., & Mecham, R. P. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109926 · Cited by 532
(1979) · PubMed · Cited by 470
Li, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00003-1 · Cited by 434
Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
Ginsberg, M. H., Partridge, A., & Shattil, S. J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.010 · Cited by 415
Ahmed, S. H., Clark, L. L., Pennington, W. R., Webb, C. S., Bonnema, D. D., Leonardi, A. H., McClure, C. D., Spinale, F. G., & Zile, M. R. (2006) · Circulation · doi:10.1161/circulationaha.105.573865 · Cited by 386
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation
Hyytiäinen, M., Penttinen, C., & Keski-Oja, J. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490460933 · Cited by 354
Boluyt, M. O., O'Neill, L., Meredith, A. L., Bing, O. H., Brooks, W. W., Conrad, C. H., Crow, M. T., & Lakatta, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.1.23 · Cited by 346
Peterson, J. T., Hallak, H., Johnson, L., Li, H., O’Brien, P. M., Sliskovic, D. R., Bocan, T. M. A., Coker, M. L., Etoh, T., & Spinale, F. G. (2001) · Circulation · doi:10.1161/01.cir.103.18.2303 · Cited by 301
Rosenkranz, S., Flesch, M., Amann, K., Haeuseler, C., Kilter, H., Seeland, U., Schlüter, K.-D., & Böhm, M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00578.2001 · Cited by 300
Abnormalities of the Extracellular Degradation of Collagen Type I in Essential Hypertension
Laviades, C., Varo, N., Fernández, J., Mayor, G., Gil, M. J., Monreal, I., & Díez, J. (1998) · Circulation · doi:10.1161/01.cir.98.6.535 · Cited by 298
Rossi, M. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00018 · Cited by 285
Inokubo, Y., Hanada, H., Ishizaka, H., Fukushi, T., Kamada, T., & Okumura, K. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112238 · Cited by 283
Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells
Eguchi, S., Dempsey, P. J., Frank, G. D., Motley, E. D., & Inagami, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008570200 · Cited by 278
BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein
Ge, G., & Greenspan, D. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606058 · Cited by 275
López, B., González, A., Querejeta, R., Larman, M., & Díez, J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.077 · Cited by 251
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234
Swaney, J. S., Roth, D. M., Olson, E. R., Naugle, J. E., Meszaros, J. G., & Insel, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408704102 · Cited by 226
Integrin Activation and Matrix Binding Mediate Cellular Responses to Mechanical Stretch
Katsumi, A., Naoe, T., Matsushita, T., Kaibuchi, K., & Schwartz, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400455200 · Cited by 225
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Li, R.-K., Li, G., Mickle, D. A. G., Weisel, R. D., Merante, F., Luss, H., Rao, V., Christakis, G. T., & Williams, W. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.874 · Cited by 211
The role of myocardial fibrillar collagen in ventricular remodeling and function
Janicki, J. S., & Brower, G. L. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129260 · Cited by 184
Norton, G. R., Tsotetsi, J., Trifunovic, B., Hartford, C., Candy, G. P., & Woodiwiss, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.6.1991 · Cited by 177
Prediction of Mortality Risk by Different Methods of Indexation for Left Ventricular Mass
Liao, Y., Cooper, R. S., Durazo-Arvizu, R., Mensah, G. A., & Ghali, J. K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00552-9 · Cited by 174
Why Is Left Ventricular Hypertrophy So Predictive of Morbidity and Mortality?
Benjamin, E. J., & Levy, D. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40499-9 · Cited by 174
Sakata, Y., Yamamoto, K., Mano, T., Nishikawa, N., Yoshida, J., Hori, M., Miwa, T., & Masuyama, T. (2004) · Circulation · doi:10.1161/01.cir.0000125741.88712.77 · Cited by 173
Schäfer, B., Marg, B., Gschwind, A., & Ullrich, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400129200 · Cited by 168
Kassiri, Z., Oudit, G. Y., Sanchez, O., Dawood, F., Mohammed, F. F., Nuttall, R. K., Edwards, D. R., Liu, P. P., Backx, P. H., & Khokha, R. (2005) · Circulation Research · doi:10.1161/01.res.0000178789.16929.cf · Cited by 165
Dystroglycan, a scaffold for the ERK–MAP kinase cascade
Spence, H. J., Dhillon, A. S., James, M., & Winder, S. J. (2004) · EMBO reports · doi:10.1038/sj.embor.7400140 · Cited by 164
Matsusaka, H., Ide, T., Matsushima, S., Ikeuchi, M., Kubota, T., Sunagawa, K., Kinugawa, S., & Tsutsui, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000208840.30778.00 · Cited by 159
Heymans, S. R. B., Lupu, F., Terclavers, S., Vanwetswinkel, B., Herbert, J., Baker, A. H., Collen, D., Carmeliet, P., & Moons, L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62228-6 · Cited by 158
Lindsey, M. L., Escobar, G. P., Mukherjee, R., Goshorn, D. K., Sheats, N. J., Bruce, J. A., Mains, I. M., Hendrick, J. K., Hewett, K. W., Gourdie, R. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.612960 · Cited by 158
Eghbali, M., Tomek, R. M., Woods, C., & Bhambi, B. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.795 · Cited by 154
Iwanaga, Y., Aoyama, T., Kihara, Y., Onozawa, Y., Yoneda, T., & Sasayama, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01756-4 · Cited by 141
Relations of Serum Aldosterone to Cardiac Structure
Vasan, R. S., Evans, J. C., Benjamin, E. J., Levy, D. A., Larson, M. G., Sundström, J., Murabito, J. M., Sam, F., Colucci, W. S., & Wilson, P. W. F. (2004) · Hypertension · doi:10.1161/01.hyp.0000124251.06056.8e · Cited by 130
Clinical aspects of hypertensive myocardial fibrosis
Dı́ez, J., López, B., González, A., & Querejeta, R. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200111000-00003 · Cited by 130
Faury, G., Garnier, S., Weiss, A. S., Wallach, J., Fülöp, T., Jacob, M., Mecham, R. P., Robert, L., & Verdetti, J. (1998) · Circulation Research · doi:10.1161/01.res.82.3.328 · Cited by 121
Serum Markers of Collagen Type I Metabolism in Spontaneously Hypertensive Rats
Dı́ez, J., Panizo, Á., Gil, M. J., Monreal, I., Hernández, M., & Pardo‐Mindán, J. (1996) · Circulation · doi:10.1161/01.cir.93.5.1026 · Cited by 120
Turnover rates of different collagen types measured by isotope ratio mass spectrometry
Rucklidge, G. J., Milne, G. T., McGaw, B. A., Milne, E., & Robins, S. P. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90095-c · Cited by 119
Levy, D. A. (1988) · Drugs · doi:10.2165/00003495-198800355-00002 · Cited by 116
Acetis, M. D., Notte, A., Accornero, F., Selvetella, G., Brancaccio, M., Vecchione, C., Sbroggió, M., Collino, F., Pacchioni, B., Lanfranchi, G., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000168028.36081.e0 · Cited by 105
Skeletal Muscle Signaling Pathway through the Dystrophin Glycoprotein Complex and Rac1
Oak, S. A., Zhou, Y. W., & Jarrett, H. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305551200 · Cited by 99
Shen, W., Gao, P., Che, Z.-Q., Ji, K., Yin, M., Chen, Y., Berk, B. C., & Zhu, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.207 · Cited by 90
Self-citationDystroglycan: important player in skeletal muscle and beyond
Cohn, R. D. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.11.005 · Cited by 89
Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors
Kassiri, Z., & Khokha, R. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0522 · Cited by 85
Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo
Kamogawa, Y., Biro, S., Maeda, M., Setoguchi, M., Hirakawa, T., Yoshida, H., & Tei, C. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00205-x · Cited by 83
Angiotensin II and extracellular matrix homeostasis
Weber, K. T., Swamynathan, S. K., Guntaka, R. V., & Sun, Y. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00125-3 · Cited by 81
Risinger, G. M., Hunt, T. S., Updike, D. L., Bullen, E. C., & Howard, E. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513513200 · Cited by 80
Schiller, M., Verrecchia, F., & Mauviel, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206871 · Cited by 77
Cardiac remodeling in systemic hypertension
Kenchaiah, S., & Pfeffer, M. A. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00168-8 · Cited by 74
Manso, A. M., Elsherif, L., Kang, S., & Ross, R. S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.004 · Cited by 68
Wang, T.-L., Yang, Y.-H., Chang, H., & Hung, C.-R. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.06.016 · Cited by 65
Yoshioka, J., Prince, R. N., Huang, H., Perkins, S. B., Cruz, F. U., MacGillivray, C., Lauffenburger, D. A., & Lee, R. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501198102 · Cited by 63
Sušić, D., Varagić, J., Ahn, J., Matavelli, L. C., & Frohlich, E. D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00660.2006 · Cited by 61
Graham, H. K., & Trafford, A. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00355.2006 · Cited by 56
Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis
pez, B. A. L., lez, A. G., & ez, J. D. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00008 · Cited by 51
Smad3 Mediates Angiotensin II– and TGF-β1–Induced Vascular Fibrosis: Smad3 Thickens the Plot
Sorescu, D. (2006) · Circulation Research · doi:10.1161/01.res.0000221824.87718.c0 · Cited by 39
Matrix metalloproteinases in pathophysiology and treatment of heart failure
Feldman, A. M., Li, Y., & McTiernan, C. F. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04151-9 · Cited by 38
Faster protein and ribosome synthesis in hypertrophying heart.
Morgan, H. E., Siehl, D. L., Chua, B. H., & Lautensack, N. (1985) · PubMed · Cited by 14
Dı́ez, J., & Hernández, M. (1996) · PubMed · Cited by 9
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Chawla, L. S., Eggers, P. W., Star, R. A., & Kimmel, P. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1214243 · Cited by 1,977
Irbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Metadata
- Authors
- Berk, B. C., Fujiwara, K., & Lehoux, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 568-575
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2060072724
- Cited by
- 902
- References
- 75
- FWCI
- 26.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.